CharlesBPorterMDFACC, FAHA, FICOS
Cardiology • Kansas City, KSProfessor, Cardiovascular Disease, University Kansas School of Medicine
Dr. Porter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
University of Kansas Med Center
4000 Cambridge MS 1023
Kansas City, KS 66160Phone+1 913-588-9697Fax+1 913-588-9450
Summary
- I founded the CardioOncology Program at the University of Kansas Medical Center in 2007. My primary commitment is to the KUMC Cardiooncology program’s advancement of patient care, research, education and training. I have continuous experience in heart failure since helping found the first cardiac transplant program in Kansas City Mo in 1985.
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Cardiovascular Disease, 1980 - 1983
University of Kansas School of MedicineResidency, Internal Medicine, 1977 - 1980- University of Kansas School of MedicineClass of 1977
Certifications & Licensure
KS State Medical License 1978 - 2025
MO State Medical License 1982 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Top MD Consumers Checkbook
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Dynamic Thoracic Impedance as a Marker for Heart Failure Decompensation Start of enrollment: 2014 Apr 01
Publications & Presentations
PubMed
- 187 citationsLamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy.Sharie B. Parks, Jessica D. Kushner, Deirdre Nauman, Donna Burgess, Susan Ludwigsen
American Heart Journal. 2008-07-01 - 67 citationsDefining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement.Joerg Herrmann, Daniel Lenihan, Saro Armenian, Ana Barac, Anne Blaes
European Heart Journal. 2022-01-31 - 510 citationsManagement of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendationsGiuseppe Curigliano, Daniel J. Lenihan, Michael G. Fradley, Sarju Ganatra, Ana Barac
Annals of Oncology. 2020-02-01
Press Mentions
Spotlight: Dr. Susan Lee, MDMay 22nd, 2024
Grant Support
- Cray Gift in Heart Failure and CardioOncologySally and Cloud Cray Jr Foundation2018–Present
Professional Memberships
- Fellow
- International Cardio-Oncology SocietyAmerican Vice President GCOS
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
